In addition, the inhibition of TGF-β-receptor signaling augments the anti-tumor function of ROR1 (receptor-tyrosine-kinase-like orphan receptor 1)-specific CAR T-cells against TNBC (58). The gene discussed is ROR1; the disease is neoplasm.